Key result
Elevated NT-proBNP predicts ~67% higher 90-day mortality after mitral valve surgery.
Why the study?
Evidence regarding the prognostic role of NT-proBNP in patients with valvular heart disease, particularly those undergoing cardiac surgery, remains limited.
Does pre-operative NT-proBNP level predict 90-day mortality and peri-operative outcomes in patients undergoing mitral valve surgery?
Cohort (n=797)
Does pre-operative NT-proBNP level predict 90-day mortality and peri-operative outcomes in patients undergoing mitral valve surgery?
Odds Ratio: 1.674 (95% CI 1.23–2.277)
Pre-operative NT-proBNP is an independent predictor of 90-day mortality and peri-operative outcomes in patients undergoing mitral valve surgery, supporting its use in pre-operative risk stratification.
No takes yet. Share an insight, caveat, or question.
May support preoperative risk stratification in mitral valve surgery; extends HF data but leaves open prospective validation.
Aloi et al. (2026) conducted a cohort in Mitral valve surgery (n=797). NT-proBNP levels was evaluated on 90-day mortality (OR 1.674, 95% CI 1.230-2.277). Elevated NT-proBNP levels independently predicted 90-day mortality in patients undergoing mitral valve surgery (OR 1.674; 95% CI 1.230-2.277).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: